{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c7b447ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip install sovai[full]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Clinical Trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sovai as sov\n",
    "\n",
    "sov.token_auth(token=\"visit https://sov.ai/profile for your token\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Prediction Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_clinical = sov.data(\"trials/predict\", full_history=True) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_clinical[\"links\"] = \"https://clinicaltrials.gov/study/\" + df_clinical[\"trial_id\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>ticker</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>links</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2010-08-12</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01181479</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>Open-Label, Randomized, Parallel Group, Study ...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.970</td>\n",
       "      <td>0.630</td>\n",
       "      <td>2882.000</td>\n",
       "      <td>0.841</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01181479</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2010-11-05</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01236768</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>An Open-Label, Randomized, Phase 3 Study Of Th...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.670</td>\n",
       "      <td>2506.000</td>\n",
       "      <td>0.846</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01236768</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2010-11-16</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01243580</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>An Open-Label Study To Evaluate Pharmacokineti...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.960</td>\n",
       "      <td>0.630</td>\n",
       "      <td>2590.000</td>\n",
       "      <td>0.793</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01243580</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2010-11-29</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01250210</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>Evaluation Of Pharmacodynamic Effects On Ovula...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.700</td>\n",
       "      <td>1084.000</td>\n",
       "      <td>0.850</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01250210</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2011-06-13</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01375946</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>A Pharmacokinetic And Wearability Study Of The...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.940</td>\n",
       "      <td>0.630</td>\n",
       "      <td>2383.000</td>\n",
       "      <td>0.783</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01375946</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        date ticker     trial_id   lead_sponsor_name  \\\n",
       "0 2010-08-12      A  NCT01181479  Agile Therapeutics   \n",
       "1 2010-11-05      A  NCT01236768  Agile Therapeutics   \n",
       "2 2010-11-16      A  NCT01243580  Agile Therapeutics   \n",
       "3 2010-11-29      A  NCT01250210  Agile Therapeutics   \n",
       "4 2011-06-13      A  NCT01375946  Agile Therapeutics   \n",
       "\n",
       "                                      official_title phase_category  \\\n",
       "0  Open-Label, Randomized, Parallel Group, Study ...        phase_3   \n",
       "1  An Open-Label, Randomized, Phase 3 Study Of Th...        phase_3   \n",
       "2  An Open-Label Study To Evaluate Pharmacokineti...        phase_1   \n",
       "3  Evaluation Of Pharmacodynamic Effects On Ovula...        phase_2   \n",
       "4  A Pharmacokinetic And Wearability Study Of The...        phase_1   \n",
       "\n",
       "   success_prediction  economic_effect  duration_prediction  \\\n",
       "0               0.970            0.630             2882.000   \n",
       "1               0.950            0.670             2506.000   \n",
       "2               0.960            0.630             2590.000   \n",
       "3               0.950            0.700             1084.000   \n",
       "4               0.940            0.630             2383.000   \n",
       "\n",
       "   success_composite                                         links  \n",
       "0              0.841  https://clinicaltrials.gov/study/NCT01181479  \n",
       "1              0.846  https://clinicaltrials.gov/study/NCT01236768  \n",
       "2              0.793  https://clinicaltrials.gov/study/NCT01243580  \n",
       "3              0.850  https://clinicaltrials.gov/study/NCT01250210  \n",
       "4              0.783  https://clinicaltrials.gov/study/NCT01375946  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Trial Information"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_describe = sov.data(\"trials/describe\", full_history=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>513998</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2021-08-06</td>\n",
       "      <td>NCT05012462</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Aphe...</td>\n",
       "      <td>ZMS-1500-2021-Apheresis</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Aphe...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>75</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>None</td>\n",
       "      <td>The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2021-08-19</td>\n",
       "      <td>2022-12-21</td>\n",
       "      <td>2021-09-20</td>\n",
       "      <td>2022-12-20</td>\n",
       "      <td>2022-12-20</td>\n",
       "      <td>Denver</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847</td>\n",
       "      <td>Vitalant Blood Donation</td>\n",
       "      <td>80230</td>\n",
       "      <td>Colorado</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2022-12-01</td>\n",
       "      <td>Characterize changes in the Relative Index dur...</td>\n",
       "      <td>1-6 hours</td>\n",
       "      <td>The primary objective of the study is to chara...</td>\n",
       "      <td>Characterize changes in blood pressure relativ...</td>\n",
       "      <td>1-6 hours; 1-6 hours; 1-6 hours; 1-6 hours</td>\n",
       "      <td>Characterize changes in blood pressure that oc...</td>\n",
       "      <td>False</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>The Study Is A Prospective, Single-Arm, Non-Ra...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>456</td>\n",
       "      <td>456.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.080</td>\n",
       "      <td>456.000</td>\n",
       "      <td>0.211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513999</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2021-11-08</td>\n",
       "      <td>NCT05125848</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Hemo...</td>\n",
       "      <td>ZMS-1500-2021-Dialysis</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Hemo...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>15</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>Hemodialysis Single Group Assignment</td>\n",
       "      <td>The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2021-11-18</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Minneapolis</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 44.97997, lon: -93.26384</td>\n",
       "      <td>DaVita Clinical Research</td>\n",
       "      <td>55404</td>\n",
       "      <td>Minnesota</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-04-01</td>\n",
       "      <td>Average Relative Index Value Following a Hemod...</td>\n",
       "      <td>Duration of post-hemodialysis recovery period ...</td>\n",
       "      <td>The primary objective is to characterize the a...</td>\n",
       "      <td>Mean Intrasubject Variability (Standard Deviat...</td>\n",
       "      <td>Duration of standard dialysis procedure (Range...</td>\n",
       "      <td>The secondary objective is to characterize int...</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss; Dialysis</td>\n",
       "      <td>The Study Is A Prospective, Single-Arm, Non-Ra...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.560</td>\n",
       "      <td>0.290</td>\n",
       "      <td>905.000</td>\n",
       "      <td>0.443</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514000</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2022-07-14</td>\n",
       "      <td>NCT05463198</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>ZMS-1600-Blood Loss Detection</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>351</td>\n",
       "      <td>4</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>Blood Loss</td>\n",
       "      <td>Subjects Undergoing Blood Donation Will Be Con...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2022-07-18</td>\n",
       "      <td>2024-08-13</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>2023-05-26</td>\n",
       "      <td>2023-04-27</td>\n",
       "      <td>Denver; Bradenton; Columbus; Chattanooga</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847; lat: 27.49893, ...</td>\n",
       "      <td>Vitalant Research Institute; SunCoast Blood Ce...</td>\n",
       "      <td>80230; 34211; 31904; 37403</td>\n",
       "      <td>Colorado; Florida; Georgia; Tennessee</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-07-01</td>\n",
       "      <td>Change in the Relative Index (RI) After Minor ...</td>\n",
       "      <td>Recovery period following donation (10 minutes)</td>\n",
       "      <td>The objective of this study is to determine if...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>The Study Is A Prospective, Non-Randomized, No...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>254</td>\n",
       "      <td>254.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.520</td>\n",
       "      <td>254.000</td>\n",
       "      <td>0.732</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514001</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NCT05740644</td>\n",
       "      <td>Clinical Evaluation Of The Zynex Monitoring Sy...</td>\n",
       "      <td>PR 2022-516</td>\n",
       "      <td>Clinical Evaluation Of The Zynex Monitoring Sy...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>Blood Loss and Saline Infusion</td>\n",
       "      <td>Healthy Subjects Undergoing A Manual Blood Los...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2023-02-23</td>\n",
       "      <td>2024-07-16</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Louisville</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 39.97776, lon: -105.13193</td>\n",
       "      <td>Clinimark</td>\n",
       "      <td>80027</td>\n",
       "      <td>Colorado</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-06-01</td>\n",
       "      <td>CM-1600 Ability to Detect Minor Blood Loss; CM...</td>\n",
       "      <td>Duration of Recovery Period following blood dr...</td>\n",
       "      <td>The objective of this study is to determine if...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>This Is A Prospective, Single-Arm, Non-Randomi...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.460</td>\n",
       "      <td>0.180</td>\n",
       "      <td>519.000</td>\n",
       "      <td>0.353</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514002</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2023-07-26</td>\n",
       "      <td>NCT05980013</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>ZMS-1500-Pa2023</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>120</td>\n",
       "      <td>2</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE; DEVICE</td>\n",
       "      <td>Whole blood donation supine</td>\n",
       "      <td>Whole blood donation supine; Whole blood donat...</td>\n",
       "      <td>Supine Donation Position; Reclined Donation Po...</td>\n",
       "      <td>Subjects Will Undergo A 1-Unit Whole Blood Don...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2023-08-07</td>\n",
       "      <td>2024-05-16</td>\n",
       "      <td>2023-08-28</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2024-04-10</td>\n",
       "      <td>Denver; Bradenton</td>\n",
       "      <td>United States; United States</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847; lat: 27.49893, ...</td>\n",
       "      <td>Vitalant Research Institute; SunCoast Blood Ce...</td>\n",
       "      <td>80230; 34211</td>\n",
       "      <td>Colorado; Florida</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>Impact of subject positioning on percent chang...</td>\n",
       "      <td>At completion of blood draw</td>\n",
       "      <td>Percent change in heart rate, forearm skin tem...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Fluid Loss; Blood Loss</td>\n",
       "      <td>The Study Is A Prospective, Non-Randomized, No...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.260</td>\n",
       "      <td>0.050</td>\n",
       "      <td>226.000</td>\n",
       "      <td>0.199</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ticker       date     trial_id  \\\n",
       "513998   ZYXI 2021-08-06  NCT05012462   \n",
       "513999   ZYXI 2021-11-08  NCT05125848   \n",
       "514000   ZYXI 2022-07-14  NCT05463198   \n",
       "514001   ZYXI 2023-02-13  NCT05740644   \n",
       "514002   ZYXI 2023-07-26  NCT05980013   \n",
       "\n",
       "                                           official_title  \\\n",
       "513998  Clinical Evaluation Of The Cm-1500 During Aphe...   \n",
       "513999  Clinical Evaluation Of The Cm-1500 During Hemo...   \n",
       "514000  Evaluation Of Physiological Variables And Dete...   \n",
       "514001  Clinical Evaluation Of The Zynex Monitoring Sy...   \n",
       "514002  Evaluation Of Physiological Variables And Dete...   \n",
       "\n",
       "                     sponsor_study_id  \\\n",
       "513998        ZMS-1500-2021-Apheresis   \n",
       "513999         ZMS-1500-2021-Dialysis   \n",
       "514000  ZMS-1600-Blood Loss Detection   \n",
       "514001                    PR 2022-516   \n",
       "514002                ZMS-1500-Pa2023   \n",
       "\n",
       "                                              brief_title  \\\n",
       "513998  Clinical Evaluation Of The Cm-1500 During Aphe...   \n",
       "513999  Clinical Evaluation Of The Cm-1500 During Hemo...   \n",
       "514000  Evaluation Of Physiological Variables And Dete...   \n",
       "514001  Clinical Evaluation Of The Zynex Monitoring Sy...   \n",
       "514002  Evaluation Of Physiological Variables And Dete...   \n",
       "\n",
       "                 lead_sponsor_name sponsor_type phase_category  \\\n",
       "513998  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "513999  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514000  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514001  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514002  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "\n",
       "            study_type  enrollment_count  number_of_locations  \\\n",
       "513998  INTERVENTIONAL                75                    1   \n",
       "513999  INTERVENTIONAL                15                    1   \n",
       "514000  INTERVENTIONAL               351                    4   \n",
       "514001  INTERVENTIONAL                20                    1   \n",
       "514002  INTERVENTIONAL               120                    2   \n",
       "\n",
       "       healthy_volunteers enrollment_type study_size_category  \\\n",
       "513998               True          ACTUAL               Small   \n",
       "513999              False          ACTUAL               Small   \n",
       "514000               True          ACTUAL              Medium   \n",
       "514001               True          ACTUAL               Small   \n",
       "514002               True          ACTUAL              Medium   \n",
       "\n",
       "       condition_keywords primary_condition intervention_type  \\\n",
       "513998                nan        Fluid Loss            DEVICE   \n",
       "513999                nan        Fluid Loss            DEVICE   \n",
       "514000                nan        Fluid Loss            DEVICE   \n",
       "514001                nan        Fluid Loss            DEVICE   \n",
       "514002                nan        Fluid Loss    DEVICE; DEVICE   \n",
       "\n",
       "               primary_intervention  \\\n",
       "513998                      CM-1500   \n",
       "513999                      CM-1500   \n",
       "514000                      CM-1600   \n",
       "514001                      CM-1600   \n",
       "514002  Whole blood donation supine   \n",
       "\n",
       "                                        intervention_name  \\\n",
       "513998                                            CM-1500   \n",
       "513999                                            CM-1500   \n",
       "514000                                            CM-1600   \n",
       "514001                                            CM-1600   \n",
       "514002  Whole blood donation supine; Whole blood donat...   \n",
       "\n",
       "                            intervention_arm_group_labels  \\\n",
       "513998                                               None   \n",
       "513999               Hemodialysis Single Group Assignment   \n",
       "514000                                         Blood Loss   \n",
       "514001                     Blood Loss and Saline Infusion   \n",
       "514002  Supine Donation Position; Reclined Donation Po...   \n",
       "\n",
       "                                 intervention_description  \\\n",
       "513998  The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...   \n",
       "513999  The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...   \n",
       "514000  Subjects Undergoing Blood Donation Will Be Con...   \n",
       "514001  Healthy Subjects Undergoing A Manual Blood Los...   \n",
       "514002  Subjects Will Undergo A 1-Unit Whole Blood Don...   \n",
       "\n",
       "       has_data_monitoring_committee  \\\n",
       "513998                         False   \n",
       "513999                         False   \n",
       "514000                         False   \n",
       "514001                         False   \n",
       "514002                         False   \n",
       "\n",
       "       responsible_party_investigator_affiliation  \\\n",
       "513998                                       None   \n",
       "513999                                       None   \n",
       "514000                                       None   \n",
       "514001                                       None   \n",
       "514002                                       None   \n",
       "\n",
       "       responsible_party_investigator_title  \\\n",
       "513998                                 None   \n",
       "513999                                 None   \n",
       "514000                                 None   \n",
       "514001                                 None   \n",
       "514002                                 None   \n",
       "\n",
       "       responsible_party_investigator_name first_posted_date  \\\n",
       "513998                                None        2021-08-19   \n",
       "513999                                None        2021-11-18   \n",
       "514000                                None        2022-07-18   \n",
       "514001                                None        2023-02-23   \n",
       "514002                                None        2023-08-07   \n",
       "\n",
       "       last_update_posted_date start_date study_completion_date  \\\n",
       "513998              2022-12-21 2021-09-20            2022-12-20   \n",
       "513999              2024-05-01        NaT                   NaT   \n",
       "514000              2024-08-13 2022-09-14            2023-05-26   \n",
       "514001              2024-07-16        NaT                   NaT   \n",
       "514002              2024-05-16 2023-08-28                   NaT   \n",
       "\n",
       "       primary_completion_date                      study_locations_city  \\\n",
       "513998              2022-12-20                                    Denver   \n",
       "513999                     NaT                               Minneapolis   \n",
       "514000              2023-04-27  Denver; Bradenton; Columbus; Chattanooga   \n",
       "514001                     NaT                                Louisville   \n",
       "514002              2024-04-10                         Denver; Bradenton   \n",
       "\n",
       "                                  study_locations_country  \\\n",
       "513998                                      United States   \n",
       "513999                                      United States   \n",
       "514000  United States; United States; United States; U...   \n",
       "514001                                      United States   \n",
       "514002                       United States; United States   \n",
       "\n",
       "                                 study_locations_geopoint  \\\n",
       "513998                      lat: 39.73915, lon: -104.9847   \n",
       "513999                      lat: 44.97997, lon: -93.26384   \n",
       "514000  lat: 39.73915, lon: -104.9847; lat: 27.49893, ...   \n",
       "514001                     lat: 39.97776, lon: -105.13193   \n",
       "514002  lat: 39.73915, lon: -104.9847; lat: 27.49893, ...   \n",
       "\n",
       "                                 study_locations_facility  \\\n",
       "513998                            Vitalant Blood Donation   \n",
       "513999                           DaVita Clinical Research   \n",
       "514000  Vitalant Research Institute; SunCoast Blood Ce...   \n",
       "514001                                          Clinimark   \n",
       "514002  Vitalant Research Institute; SunCoast Blood Ce...   \n",
       "\n",
       "               study_locations_zip                  study_locations_state  \\\n",
       "513998                       80230                               Colorado   \n",
       "513999                       55404                              Minnesota   \n",
       "514000  80230; 34211; 31904; 37403  Colorado; Florida; Georgia; Tennessee   \n",
       "514001                       80027                               Colorado   \n",
       "514002                80230; 34211                      Colorado; Florida   \n",
       "\n",
       "       standard_age_groups  sex  minimum_age  maximum_age overall_status  \\\n",
       "513998  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "513999  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514000  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514001  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514002  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "\n",
       "       status_category status_verified_date  \\\n",
       "513998       completed           2022-12-01   \n",
       "513999       completed           2024-04-01   \n",
       "514000       completed           2024-07-01   \n",
       "514001       completed           2024-06-01   \n",
       "514002       completed           2024-05-01   \n",
       "\n",
       "                                primary_outcomes_measures  \\\n",
       "513998  Characterize changes in the Relative Index dur...   \n",
       "513999  Average Relative Index Value Following a Hemod...   \n",
       "514000  Change in the Relative Index (RI) After Minor ...   \n",
       "514001  CM-1600 Ability to Detect Minor Blood Loss; CM...   \n",
       "514002  Impact of subject positioning on percent chang...   \n",
       "\n",
       "                              primary_outcomes_timeframes  \\\n",
       "513998                                          1-6 hours   \n",
       "513999  Duration of post-hemodialysis recovery period ...   \n",
       "514000    Recovery period following donation (10 minutes)   \n",
       "514001  Duration of Recovery Period following blood dr...   \n",
       "514002                        At completion of blood draw   \n",
       "\n",
       "                            primary_outcomes_descriptions  \\\n",
       "513998  The primary objective of the study is to chara...   \n",
       "513999  The primary objective is to characterize the a...   \n",
       "514000  The objective of this study is to determine if...   \n",
       "514001  The objective of this study is to determine if...   \n",
       "514002  Percent change in heart rate, forearm skin tem...   \n",
       "\n",
       "                              secondary_outcomes_measures  \\\n",
       "513998  Characterize changes in blood pressure relativ...   \n",
       "513999  Mean Intrasubject Variability (Standard Deviat...   \n",
       "514000                                               None   \n",
       "514001                                               None   \n",
       "514002                                               None   \n",
       "\n",
       "                            secondary_outcomes_timeframes  \\\n",
       "513998         1-6 hours; 1-6 hours; 1-6 hours; 1-6 hours   \n",
       "513999  Duration of standard dialysis procedure (Range...   \n",
       "514000                                               None   \n",
       "514001                                               None   \n",
       "514002                                               None   \n",
       "\n",
       "                          secondary_outcomes_descriptions  has_results  \\\n",
       "513998  Characterize changes in blood pressure that oc...        False   \n",
       "513999  The secondary objective is to characterize int...         True   \n",
       "514000                                               None         True   \n",
       "514001                                               None         True   \n",
       "514002                                               None        False   \n",
       "\n",
       "                    conditions  \\\n",
       "513998              Fluid Loss   \n",
       "513999    Fluid Loss; Dialysis   \n",
       "514000              Fluid Loss   \n",
       "514001              Fluid Loss   \n",
       "514002  Fluid Loss; Blood Loss   \n",
       "\n",
       "                                            brief_summary  \\\n",
       "513998  The Study Is A Prospective, Single-Arm, Non-Ra...   \n",
       "513999  The Study Is A Prospective, Single-Arm, Non-Ra...   \n",
       "514000  The Study Is A Prospective, Non-Randomized, No...   \n",
       "514001  This Is A Prospective, Single-Arm, Non-Randomi...   \n",
       "514002  The Study Is A Prospective, Non-Randomized, No...   \n",
       "\n",
       "       detailed_description masking      allocation intervention_model  \\\n",
       "513998                 None    NONE              NA       SINGLE_GROUP   \n",
       "513999                 None    NONE              NA       SINGLE_GROUP   \n",
       "514000                 None    NONE              NA       SINGLE_GROUP   \n",
       "514001                 None    NONE              NA       SINGLE_GROUP   \n",
       "514002                 None    NONE  NON_RANDOMIZED           PARALLEL   \n",
       "\n",
       "       primary_purpose  has_expanded_access  study_duration_days  \\\n",
       "513998      DIAGNOSTIC                False                  456   \n",
       "513999      DIAGNOSTIC                False                 <NA>   \n",
       "514000      DIAGNOSTIC                False                  254   \n",
       "514001      DIAGNOSTIC                False                 <NA>   \n",
       "514002      DIAGNOSTIC                False                 <NA>   \n",
       "\n",
       "        trial_duration references_type references_citation references_pmid  \\\n",
       "513998         456.000            None                None            None   \n",
       "513999             NaN            None                None            None   \n",
       "514000         254.000            None                None            None   \n",
       "514001             NaN            None                None            None   \n",
       "514002             NaN            None                None            None   \n",
       "\n",
       "       collaborators_name collaborators_class ipd_sharing  success_prediction  \\\n",
       "513998               None                None          NO               0.270   \n",
       "513999               None                None        None               0.560   \n",
       "514000               None                None          NO               0.910   \n",
       "514001               None                None          NO               0.460   \n",
       "514002               None                None          NO               0.260   \n",
       "\n",
       "        economic_effect  duration_prediction  success_composite  \n",
       "513998            0.080              456.000              0.211  \n",
       "513999            0.290              905.000              0.443  \n",
       "514000            0.520              254.000              0.732  \n",
       "514001            0.180              519.000              0.353  \n",
       "514002            0.050              226.000              0.199  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_describe.tail()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Specific Tickers Select"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_pfizer = sov.data(\"trials/predict\", tickers=[\"PFE\"]) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>ticker</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>513354</th>\n",
       "      <td>1999-10-18</td>\n",
       "      <td>WINT</td>\n",
       "      <td>NCT00004500</td>\n",
       "      <td>Windtree Therapeutics</td>\n",
       "      <td>A Multicenter, Randomized, Controlled Trial Co...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.060</td>\n",
       "      <td>0.490</td>\n",
       "      <td>1841.000</td>\n",
       "      <td>0.279</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512527</th>\n",
       "      <td>1999-10-18</td>\n",
       "      <td>UTHR</td>\n",
       "      <td>NCT00004497</td>\n",
       "      <td>United Therapeutics</td>\n",
       "      <td>None</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.600</td>\n",
       "      <td>5637.000</td>\n",
       "      <td>0.805</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32118</th>\n",
       "      <td>1999-10-29</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT00000174</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>None</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.490</td>\n",
       "      <td>2065.000</td>\n",
       "      <td>0.770</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36726</th>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>PFE</td>\n",
       "      <td>NCT00003343</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>A Randomized, Double-Blind, Placebo-Controlled...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.300</td>\n",
       "      <td>0.170</td>\n",
       "      <td>4664.000</td>\n",
       "      <td>0.290</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36723</th>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>PFE</td>\n",
       "      <td>NCT00003720</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>A Multicenter, Dose Escalating Study In Patien...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.600</td>\n",
       "      <td>4679.000</td>\n",
       "      <td>0.742</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20808</th>\n",
       "      <td>2024-10-25</td>\n",
       "      <td>GSK</td>\n",
       "      <td>NCT06663436</td>\n",
       "      <td>Glaxosmithkline</td>\n",
       "      <td>A Phase 2 Single-Blind, Randomized, Controlled...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.840</td>\n",
       "      <td>0.430</td>\n",
       "      <td>327.000</td>\n",
       "      <td>0.704</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32829</th>\n",
       "      <td>2024-10-27</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT06662812</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>Disease Characteristics And Treatment Patterns...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.070</td>\n",
       "      <td>730.000</td>\n",
       "      <td>0.204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32830</th>\n",
       "      <td>2024-10-27</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT06662825</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>Seg-2022-01 Patient Characteristics And Treatm...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.310</td>\n",
       "      <td>0.070</td>\n",
       "      <td>323.000</td>\n",
       "      <td>0.233</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511796</th>\n",
       "      <td>2024-10-28</td>\n",
       "      <td>TEVA</td>\n",
       "      <td>NCT06664619</td>\n",
       "      <td>Teva Branded Pharmaceutical Products R&amp;D, Inc.</td>\n",
       "      <td>A 4-Week, Double-Blind, Placebo-Controlled, Pa...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.850</td>\n",
       "      <td>0.440</td>\n",
       "      <td>560.000</td>\n",
       "      <td>0.727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513423</th>\n",
       "      <td>2024-10-28</td>\n",
       "      <td>XBIT</td>\n",
       "      <td>NCT06664502</td>\n",
       "      <td>Eyebiotech Ltd.</td>\n",
       "      <td>A Phase 1/2A 2-Part Study Consisting Of An Ope...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.870</td>\n",
       "      <td>0.470</td>\n",
       "      <td>550.000</td>\n",
       "      <td>0.731</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>48998 rows Ã 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             date ticker     trial_id  \\\n",
       "513354 1999-10-18   WINT  NCT00004500   \n",
       "512527 1999-10-18   UTHR  NCT00004497   \n",
       "32118  1999-10-29    NVS  NCT00000174   \n",
       "36726  1999-11-01    PFE  NCT00003343   \n",
       "36723  1999-11-01    PFE  NCT00003720   \n",
       "...           ...    ...          ...   \n",
       "20808  2024-10-25    GSK  NCT06663436   \n",
       "32829  2024-10-27    NVS  NCT06662812   \n",
       "32830  2024-10-27    NVS  NCT06662825   \n",
       "511796 2024-10-28   TEVA  NCT06664619   \n",
       "513423 2024-10-28   XBIT  NCT06664502   \n",
       "\n",
       "                                     lead_sponsor_name  \\\n",
       "513354                           Windtree Therapeutics   \n",
       "512527                             United Therapeutics   \n",
       "32118                                         Novartis   \n",
       "36726                                           Pfizer   \n",
       "36723                                           Pfizer   \n",
       "...                                                ...   \n",
       "20808                                  Glaxosmithkline   \n",
       "32829                                         Novartis   \n",
       "32830                                         Novartis   \n",
       "511796  Teva Branded Pharmaceutical Products R&D, Inc.   \n",
       "513423                                 Eyebiotech Ltd.   \n",
       "\n",
       "                                           official_title phase_category  \\\n",
       "513354  A Multicenter, Randomized, Controlled Trial Co...        phase_3   \n",
       "512527                                               None        phase_3   \n",
       "32118                                                None        phase_3   \n",
       "36726   A Randomized, Double-Blind, Placebo-Controlled...        phase_3   \n",
       "36723   A Multicenter, Dose Escalating Study In Patien...        phase_1   \n",
       "...                                                   ...            ...   \n",
       "20808   A Phase 2 Single-Blind, Randomized, Controlled...        phase_2   \n",
       "32829   Disease Characteristics And Treatment Patterns...  not_specified   \n",
       "32830   Seg-2022-01 Patient Characteristics And Treatm...  not_specified   \n",
       "511796  A 4-Week, Double-Blind, Placebo-Controlled, Pa...        phase_3   \n",
       "513423  A Phase 1/2A 2-Part Study Consisting Of An Ope...        phase_2   \n",
       "\n",
       "        success_prediction  economic_effect  duration_prediction  \\\n",
       "513354               0.060            0.490             1841.000   \n",
       "512527               0.950            0.600             5637.000   \n",
       "32118                0.920            0.490             2065.000   \n",
       "36726                0.300            0.170             4664.000   \n",
       "36723                0.910            0.600             4679.000   \n",
       "...                    ...              ...                  ...   \n",
       "20808                0.840            0.430              327.000   \n",
       "32829                0.270            0.070              730.000   \n",
       "32830                0.310            0.070              323.000   \n",
       "511796               0.850            0.440              560.000   \n",
       "513423               0.870            0.470              550.000   \n",
       "\n",
       "        success_composite  \n",
       "513354              0.279  \n",
       "512527              0.805  \n",
       "32118               0.770  \n",
       "36726               0.290  \n",
       "36723               0.742  \n",
       "...                   ...  \n",
       "20808               0.704  \n",
       "32829               0.204  \n",
       "32830               0.233  \n",
       "511796              0.727  \n",
       "513423              0.731  \n",
       "\n",
       "[48998 rows x 10 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical.sort_values(\"date\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#https://clinicaltrials.gov/study/NCT06628310"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.10"
  },
  "vscode": {
   "interpreter": {
    "hash": "b7bc88ef2312de8ccb6fe32ee45ed1b303064bae6342b11333199520ddc77aae"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
